Evidence map›Paper›PMID 41987929›Full record

ArticleFrontiers in neuroscience2026

The impact of the Lab4 probiotic on neurodegenerative processes in a murine Alzheimer's disease model.

Timothy R Hughes, Thomas S Webberley, Daniel John, Sophie Thomas, Joshua Kerry-Smith, Daryn R Michael, Ryan J Bevan, James E Morgan, Sue Plummer

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Timothy R HughesSystems Immunity Research Institute, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Thomas S WebberleySystems Immunity Research Institute, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Daniel JohnCultech Ltd., Baglan Industrial Park, Neath Port Talbot, United Kingdom.
Sophie ThomasCultech Ltd., Baglan Industrial Park, Neath Port Talbot, United Kingdom.
Joshua Kerry-SmithCultech Ltd., Baglan Industrial Park, Neath Port Talbot, United Kingdom.
Daryn R MichaelCultech Ltd., Baglan Industrial Park, Neath Port Talbot, United Kingdom.
Ryan J BevanUK Dementia Research Institute, Cardiff University, Cardiff, United Kingdom.
James E MorganSchool of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom.
Sue PlummerCultech Ltd., Baglan Industrial Park, Neath Port Talbot, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The gut-brain-axis is increasingly recognised as a mediator of neurodegenerative processes, with the gut microbiota emerging as a potential target for intervention. The Lab4 probiotic has demonstrated neuroprotective activity Method: Male 3xTg-AD mice were fed a high fat diet (to accelerate neurodegeneration) with or without daily Lab4 probiotic supplementation for 84 days. Endpoints included hippocampal neuronal spine density, novel object recognition, whole-brain gene expression, plasma cytokines/lipids, body weight, and faecal microbiota composition. Results: Lab4 Probiotic supplementation preserved the neuronal spine density, particularly thin spines, and improved recognition memory. Gene expression analysis of whole brain extracts detected reductions in pro-inflammatory markers (IL-5 and Caspase-1) and plasma analysis revealed reduced levels of pro-inflammatory TNF- Discussion: These preliminary findings highlight a neuroprotective impact in 3xTg-AD mice receiving the Lab4 probiotic and warrant more extensive assessments in murine models and/or human subjects.

Indexed as

Alzheimer’s diseasecognitioninflammationmicrobiotaneurodegenerationprobiotics

Identifiers

PMID41987929
PMCPMC13076349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.